173 related articles for article (PubMed ID: 35995596)
21. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of interstitial lung abnormalities in middle-aged never-smokers.
Pesonen I; Johansson F; Johnsson Å; Blomberg A; Boijsen M; Brandberg J; Cederlund K; Egesten A; Emilsson ÖI; Engvall JE; Frølich A; Hagström E; Lindberg E; Malinovschi A; Stenfors N; Swahn E; Tanash H; Themudo R; Torén K; Vanfleteren LEGW; Wollmer P; Zaigham S; Östgren CJ; Sköld CM
ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753274
[TBL] [Abstract][Full Text] [Related]
23. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection.
Sangani RG; Deepak V; Ghio AJ; Forte MJ; Zulfikar R; Patel Z; King A; Alshaikhnassir E; Abbas G; Vos J
BMC Pulm Med; 2022 Apr; 22(1):172. PubMed ID: 35488260
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy.
García Mullor MM; Arenas-Jiménez JJ; Ureña Vacas A; Gayá García-Manso I; Pérez Pérez JL; Serra Serra N; García Sevila R
Radiologia (Engl Ed); 2024 Apr; 66 Suppl 1():S10-S23. PubMed ID: 38642956
[TBL] [Abstract][Full Text] [Related]
25. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Follow-Up of Interstitial Lung Abnormality: Implication in Follow-Up Strategy and Risk Thresholds.
Park S; Choe J; Hwang HJ; Noh HN; Jung YJ; Lee JB; Do KH; Chae EJ; Seo JB
Am J Respir Crit Care Med; 2023 Oct; 208(8):858-867. PubMed ID: 37590877
[No Abstract] [Full Text] [Related]
27. Are interstitial lung abnormalities associated with COPD? A nested case-control study.
Bozzetti F; Paladini I; Rabaiotti E; Franceschini A; Alfieri V; Chetta A; Crisafulli E; Silva M; Pastorino U; Sverzellati N
Int J Chron Obstruct Pulmon Dis; 2016; 11():1087-96. PubMed ID: 27307724
[TBL] [Abstract][Full Text] [Related]
28. Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer.
Im Y; Chung MP; Lee KS; Han J; Chung MJ; Kim HK; Cho JH; Choi YS; Park S; Kim HJ; Kwon OJ; Park B; Yoo H
Thorax; 2023 Feb; 78(2):183-190. PubMed ID: 35688622
[TBL] [Abstract][Full Text] [Related]
29. Increased respiratory morbidity in individuals with interstitial lung abnormalities.
Hoyer N; Thomsen LH; Wille MMW; Wilcke T; Dirksen A; Pedersen JH; Saghir Z; Ashraf H; Shaker SB
BMC Pulm Med; 2020 Mar; 20(1):67. PubMed ID: 32188453
[TBL] [Abstract][Full Text] [Related]
30. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
31. Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis.
Zhu M; Yi J; Su Y; Zhang Y; Gao Y; Xu X; Zhang S; Zhang Y; Huang K
Thorac Cancer; 2023 Jul; 14(19):1874-1882. PubMed ID: 37232276
[TBL] [Abstract][Full Text] [Related]
32. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.
Putman RK; Gudmundsson G; Axelsson GT; Hida T; Honda O; Araki T; Yanagawa M; Nishino M; Miller ER; Eiriksdottir G; Gudmundsson EF; Tomiyama N; Honda H; Rosas IO; Washko GR; Cho MH; Schwartz DA; Gudnason V; Hatabu H; Hunninghake GM
Am J Respir Crit Care Med; 2019 Jul; 200(2):175-183. PubMed ID: 30673508
[No Abstract] [Full Text] [Related]
33. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.
Araki T; Putman RK; Hatabu H; Gao W; Dupuis J; Latourelle JC; Nishino M; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Schwartz DA; Rosas IO; Washko GR; O'Connor GT; Hunninghake GM
Am J Respir Crit Care Med; 2016 Dec; 194(12):1514-1522. PubMed ID: 27314401
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers.
McDermott GC; Hayashi K; Yoshida K; Moll M; Cho MH; Doyle TJ; Kinney GL; Dellaripa PF; Putman RK; San Jose Estepar R; Hata A; Hino T; Hida T; Yanagawa M; Nishino M; Washko G; Regan EA; Hatabu H; Hunninghake GM; Silverman EK; Sparks JA
Rheumatology (Oxford); 2023 Oct; 62(SI3):SI286-SI295. PubMed ID: 37871923
[TBL] [Abstract][Full Text] [Related]
35. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
[TBL] [Abstract][Full Text] [Related]
36. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Salisbury ML; Hewlett JC; Ding G; Markin CR; Douglas K; Mason W; Guttentag A; Phillips JA; Cogan JD; Reiss S; Mitchell DB; Wu P; Young LR; Lancaster LH; Loyd JE; Humphries SM; Lynch DA; Kropski JA; Blackwell TS
Am J Respir Crit Care Med; 2020 May; 201(10):1230-1239. PubMed ID: 32011901
[No Abstract] [Full Text] [Related]
37. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
Chae KJ; Chung MJ; Jin GY; Song YJ; An AR; Choi H; Goo JM
Eur Radiol; 2022 Apr; 32(4):2713-2723. PubMed ID: 34984519
[TBL] [Abstract][Full Text] [Related]
38. Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival.
Iwasawa T; Okudela K; Takemura T; Fukuda T; Matsushita S; Baba T; Ogura T; Tajiri M; Yoshizawa A
Radiology; 2019 Aug; 292(2):489-498. PubMed ID: 31161974
[TBL] [Abstract][Full Text] [Related]
39. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
40. The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study.
Sanders JL; Axelsson G; Putman R; Menon A; Dupuis J; Xu H; Wang S; Murabito J; Vasan R; Araki T; Nishino M; Washko GR; Hatabu H; O'Connor G; Gudmundsson G; Gudnason V; Hunninghake GM
Thorax; 2023 Jun; 78(6):559-565. PubMed ID: 35777957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
